• Questions Raised During Live Facebook Session Were Eye-opening
  • FDA Grants Orphan Drug Designation to Samumed’s Investigational SM04646 for IPF Treatment
  • Things to Consider When Seeking Patient Advocates
  • Ofev Corrects Blood Vessel Abnormalities Associated with Lung Fibrosis, Study Suggests
  • Two Medical Centers Adopt ZappRx’s Digital Platform to Ease Prescription of Specialty Medications
  • Esbriet, Ofev Safety Profiles in Routine Practice Similar to Clinical Trial Reports, Study Finds
  • How Relationships Can Change with a Diagnosis of IPF
  • Samumed’s Candidate PF Therapy, SM04646, Found to Be Well-tolerated and Safe in Phase 1 Trial
  • Some Tips and Resources to Help Tackle Your Sleep Problems
  • Social Media and My IPF Story: A Public to Private Journey
  • Esbriet, Ofev Remain Only Effective IPF Therapies Though PRM-151 is Gaining Ground, Comparison Study Finds
  • Northwestern Researchers Find New Link Between Immune Cells and Pulmonary Fibrosis